News

AI can identify genetic perturbations from cell images, offering new path for drug discovery
Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to ...
New Haven biotech firm to cut 40% of workforce in latest round of layoffs, pivots on drug program
RallyBio will lay off 40% of its New Haven workforce as it shifts focus to new drug programs and streamlines operations.